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Mouse model to study the replication of primate foamy viruses
Abstract
A mouse model was developed to study the virus-host interaction of molecularly cloned human foamy
virus (HFV) in vivo. The infectious process was analysed in two mouse strains, CBA/Ca and C57BL/6J,
over a period of 24 weeks by PCR on DNAs from various animal tissues; virus serology was examined
by immunoblotting. The infection persisted in both mouse strains and did not induce clinical symptoms.
Upon infection of adult CBA/Ca mice HFV became detectable by PCR in an increasing number of
organs over time. In contrast, in C57BL/6J mice, after an initial phase of dissemination, viral DNA
sequences were found only in a few organs. Interestingly, the different course of infection was
accompanied by differences in the antiviral immune response. In particular, C57BL/6J mice were high
responders with respect to antibodies to the viral Bet protein, while CBA/Ca mice were low responders.
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A mouse model was developed to study the virus–
host interaction of molecularly cloned human foamy
virus (HFV) in vivo. The infectious process was
analysed in two mouse strains, CBA/Ca and C57BL/
6J, over a period of 24 weeks by PCR on DNAs from
various animal tissues; virus serology was examined
by immunoblotting. The infection persisted in both
mouse strains and did not induce clinical symptoms.
Upon infection of adult CBA/Ca mice HFV became
detectable by PCR in an increasing number of
organs over time. In contrast, in C57BL/6J mice,
after an initial phase of dissemination, viral DNA
sequences were found only in a few organs.
Interestingly, the different course of infection was
accompanied by differences in the antiviral immune
response. In particular, C57BL/6J mice were high
responders with respect to antibodies to the viral
Bet protein, while CBA/Ca mice were low
responders.
In vitro studies on foamy viruses (FVs) have disclosed some
interesting properties of this group of retroviruses (for reviews
see Rethwilm, 1995, 1996). However, there have been only a
few investigations on the interaction of FVs with the living
host which use modern molecular biology techniques (von
Laer et al., 1996 ; Saib et al., 1997). Appropriate animal studies
could reveal interesting information concerning the nature of
FV target cells, viral gene expression, requirements of
accessory genes for virus replication, the mechanism of virus
persistence and the role of the immune system in counteracting
virus replication. There are no suitable animal models, based on
inbred rodent strains and molecularly cloned virus, for other
complexly regulated primate retroviruses. We therefore es-
tablished a mouse model to study the replication of FVs in vivo
using the so-called human FV isolate (HFV2) (Schmidt et al.,
1997).
To determine whether rodents can be productively infected
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with primate FV, we infected one litter of newborns and four
adults of six mouse strains (C3H}He, CBA}Ca, C57BL}6J,
DBA}1, DBA}2 and SJL) and six rat strains (DA, Lew,
WKY}N, LE}Cpb, BN}SsN and PVG) (animals were purchased
from Harlan and Winkelmann) with 10' infectious units of cell-
bound HFV2 by intraperitoneal (i.p.) injection. At 4 and 8
weeks p.i. two animals from each group were sacrificed and
analysed for the presence of FV. The spleens of individual
animals were divided into two. One half was used for virus re-
isolation by co-cultivation with MRC-5 cells and DNA was
extracted from the other half for nested FV PCR using pol gene
primers (see Fig. 1 legend). In addition, we tested the anti-HFV
immune response by Western blotting (WB). Since we used
cell-bound virus in this experiment a WB reaction was regarded
as positive only if an immune response against the Tas}Bel-1
transactivator protein developed between 4 and 8 weeks p.i.
Such antibodies developed in some rodent strains infected as
neonates (DBA}1, C57BL}6J, BN}SsN and WKY}N) and in
some strains infected as adults (DBA}1, SJL, C57BL}6J,
BN}SsN, DA, WKY}N and Lew). All infected animals were
found to be positive by PCR on spleen cell DNA (data not
shown). Aseptically removed spleen cells (2¬10' cells}ml)
were co-cultivated after stimulation with 10 lg}ml lipopoly-
saccharide (Sigma) and 3 lg}ml concanavalin A (Pharmacia)
with MRC-5 cells for 1 week. Fibroblasts were subcultured for
an additional 3–7 weeks ; however, HFV was recovered only
occasionally from BN}SsN and DA rats infected as neonates
and from one CBA}Ca mouse infected as an adult. Animals
appeared to tolerate the infection well and no apparent signs of
disease that could be attributed to FV infection were identified.
This systematic test of susceptibility revealed that different
strains of inbred rats and mice could be infected with
molecularly cloned FV. We chose CBA}Ca and C57BL}6J
mice for further analyses because of the different immune
response to the virus in these two strains.
Using cell-free HFV2 (a freeze–thaw lysate of infected cells
cleared by low-speed centrifugation and passed through a
0±45 lm filter), adult CBA}Ca and C57BL}6J mice were
infected by the i.p. route with 10' infectious units and the
course of infection was monitored over a period of 24 weeks.
Six mice for each time-point (4, 8, 12 and 24 weeks p.i.) were
analysed for the presence of FV DNA in different organs by
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Fig. 1. Course of FV infection in CBA/Ca
and C57BL/6J mice. Adult CBA/Ca and
C57BL/6J mice were infected by the i.p.
route with 106 infectious units of cell-free
HFV2. At 4, 8, 12 and 24 weeks p.i., six
animals of each strain were sacrificed,
perfused (Schwender et al., 1991) and
analysed. (A) Detection of HFV DNA in
different organs of infected animals by






prepared individually and DNA was
extracted using the Qiaamp tissue kit
(Qiagen); 1 lg of DNA was used for the
amplification by PCR. The conditions of
amplification were essentially as
described previously (Schweizer et al.,
1994, 1995). For the detection of
positive results, half of the DNA was run
on an ethidium bromide-containing 1±5%
agarose gel and photographed. Of the six
samples of each organ analysed, the
number of samples that tested positive
for HFV by PCR are given. (B) Typical
antibody response of infected CBA/Ca
and C57BL/6J mice determined by WB
reaction on strips coated with HFV2-
infected MRC-5 lysate (Hahn et al.,
1994). The migration of molecular mass
markers is indicated on the left. Note that
CBA/Ca mice did not produce detectable
Bet antibodies.
PCR with pol gene primers, the development of an anti-FV
immune response by WB and virus isolation from spleen cells.
As shown in Fig. 1 (A), we noted a marked difference between
CBA}Ca and C57BL}6J mice in the detectability of FV DNA
in different organs. In CBA}Ca mice after 4 weeks p.i. only a
few animals tested positive, but over time the number of
positive animals and the number of positive organs per animal
increased. In C57BL}6J mice a different scenario was observed ;
the number of positive animals and organs was maximal in the
early phase of infection (4 and 8 weeks p.i.) and then gradually
declined.
Analysis of the anti-FV immune response (Fig. 1B) revealed
that C57BL}6J mice mounted a strong anti-Gag and anti-Bet
immune response as is usually observed by WB in primates
naturally infected with FV (Netzer et al., 1990 ; Hahn et al.,
1994 ; Ro$ sener et al., 1996). In contrast, adult CBA}Ca mice
developed a weaker anti-FV Gag immune response and had no
detectable Bet antibodies. Only one CBA}Ca mouse infected
for 24 weeks was positive for virus isolation. However, this
result provided further evidence that HFV infection persisted.
Analysis of CBA}Ca and C57BL}6J mice, infected with the
cell-free virus as neonates, at 4 and 24 weeks p.i. revealed that,
using bel gene primers, FV DNA could be detected in the vast
majority of animals and organs at both time-points (Table 1).
Consistent with the result obtained with animals infected as
adults, CBA}Ca mice developed a clearly weaker anti-FV
immune response compared with that observed in C57BL}6J
mice, as determined by WB (Table 1). Gag antibodies were
detected 24 weeks after infection in four CBA}Ca mice, one of
which also showed Bet and Tas}Bel-1 antibodies. At this time-
point, all infected C57BL}6J mice had built up a strong immune
response against all three FV proteins. However, compared
with C57BL}6J mice infected as adults, the development of an
anti-Bet immune response in infected neonates was not
accompanied by a restriction of the virus infection. An
immature immune system leading to an initial lag phase before
BJDA
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Table 1. Course of HFV2 infection in newborn CBA/Ca
and C57BL/6J mice
Twelve newborn CBA}Ca and C57BL}6J mice were each infected by
the i.p. route with 10' infectious units of cell-free HFV2. Six mice of
each strain were sacrificed and analysed after 4 and 24 weeks. The
numbers indicate positive results per six animals per organ.
CBA/Ca C57BL/6J
Weeks p.i … 4 24 4 24
PCR* Spleen 4 5 4 3
Thymus 4 5 4 4
Ovaries 6 5 4 6
Lung 5 5 4 6
Liver 6 5 4 5
CNS 1 0 3 0
WB a-Gag 2 4 5 6
a-Bet 0 1 4 6
a-Tas}Bel-1 0 1 0 6
* Nested PCR was performed using the bel-gene-specific primers
(g293, AAATCCTCGACGCCCCAGACGATA; g294, CGAGGC-
TTGTGATGCTTTTCAAAC; g295, AGTGAGCTTGTTGGC-
CCTGAAAAT; g296, GTTTGGTAGGTTGCTGGACTCTTC)
as described in the Fig. 1 legend.
 One CBA}Ca animal was WB negative and PCR negative in all
tested organs.
FV antibodies develop and high cell division rates in the
infected neonates may be responsible for this. No infectious
virus was re-isolated from animals infected as neonates.
Some CBA}Ca and C57BL}6J mice infected as adults or as
neonates were kept for a period of 50 weeks or longer. When
spleen cell DNAs were analysed by PCR, persistent HFV
infection could be demonstrated in the majority of the animals
(9 out of 13) (data not shown).
We have shown recently that the HFV isolate has
undergone deletions in the U3 region of the long terminal
repeat (LTR) upon long-term replication in human diploid
fibroblast cell cultures (Schmidt et al., 1997). At least one of the
deletion variants (HSRV1) appeared to be replication com-
petent in vivo in an accidentally infected human. We therefore
wanted to know how the HFV LTR behaved in persistently
infected mice. To investigate the replication competence of
FVs with LTR deletions we infected adult CBA}Ca and
C57BL}6J mice by the i.p. route with 10' infectious units of
cell-associated : (i) HFV2; (ii) HSRV2; (iii) a virus mixture
consisting of HFV2 (10%) and HSRV2 (90%) ; or (iv) HFVwt
from 1985, consisting mainly of the HSRV1 variant and trace
amounts of HFV2 (Schmidt et al., 1997). As shown in Table 2,
all viruses were able to infect the two mouse strains. Analysis
of spleen cell DNA with the LTR primers revealed that the
dominant virus in the infecting pool (HSRV2 in the HSRV2}
HFV2 mixture and HSRV1 in HFVwt) was also the dominant
variant in the infected mice.
In some studies, rabbits and mice have already been used as
infection models for HFV and simian foamy viruses (SFVs)
(Johnston, 1974 ; Swack & Hsiung, 1975 ; Hooks & Detrick-
Hooks, 1979 ; Brown et al., 1982 ; Santillana-Hayat et al., 1993 ;
Saib et al., 1997). While Hooks & Detrick-Hooks (1979) used
rabbits for infection with the chimpanzee isolate SFV-7 to
investigate a transient suppression of cellular immunity, Brown
et al. (1982) reported the persistent asymptomatic infection of
outbred Swiss-Webster white mice with the chimpanzee virus
SFV-6. In the latter study, a high frequency of SFV-6 re-
isolations from explanted spleenic cultures in the initial phase
of infection was reported. In none of these studies was
molecularly cloned virus used.
The frequency of virus re-isolation was very low in all our
experiments (HFV was re-isolated from 2 out of a total of
52 infected adult CBA}Ca mice). Differences in the genetic
background of the mice, the methods used for virus isolation,
and the use of a defined molecularly cloned virus instead of a
more heterogeneous wild-type virus may explain the different
results between our study and that of Brown et al. (1982).
However, for virus detection, the PCR technique was evidently
a good substitute for virus isolation.
Mice transgenic for HFV have been reported to develop a
fatal encephalopathy and myopathy (for a review see Aguzzi
et al., 1996). Clinical signs of disease were not seen in mice
infected with HFV either as adults or as newborns. The lack of
HFV neurotropism after experimental i.p. infection and the
anti-HFV immune response even after infection of newborns,
which is not observed in HFV transgenic mice, may explain
this discrepancy.
Three molecular clones of HFV which are replication
competent in cell culture have been characterized recently
(Schmidt et al., 1997). These viruses differ in the lengths of their
LTR U3 elements. Only the pHFV2 clone represents the
complete HFV genome, while pHSRV1 and 2 are non-random
U3 deletion variants. Such LTR deletion variants are not found
in naturally infected chimpanzees ; however, the HSRV1 virus
was dominant, if not exclusively present, in an accidentally
infected human (Schmidt et al., 1997). Consistent with this, all
three viruses were able to infect CBA}Ca and C57BL}6J mice.
Furthermore, when the inoculum consisted of a mixture of
viruses with different U3 lengths, the dominant virus in the
inoculum became the dominant virus in vivo. However, future
studies may reveal more subtle in vivo differences between
LTR-deleted and full-length virus, e.g. with respect to organ
and cell tropism.
Although apes and monkeys are the natural hosts of
primate FVs, our study suggests that a mouse model (CBA}Ca
and C57BL}6J mice infected with HFV) can be used to
investigate various aspects of the FV–host interaction. The
function of the Bet protein is of prime interest. Bet is not
strictly required for replication of HFV in cell-culture although
BJDB
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Table 2. Detection of HFV U3 deletion variants in
spleens of mice infected with different HFV molecular
clones
Four groups of six adult CBA}Ca and C57BL}6J mice were infected
with 10' infectious units of four different cell-bound virus
preparations. HFV2 represents the full-length HFV infectious molecular
clone (Schmidt et al., 1997). HSRV2 is the molecular clone of a
naturally occurring 646 bp U3 deletion variant (Schmidt et al., 1997 ;
Schmidt & Rethwilm, 1995). HSRV2}HFV2 is a mixture of both
viruses containing 90% infectious units of HSRV2 and 10% infectious
units of HFV2. HFVwt is derived from a wild-type passage stored
frozen since 1985. This virus contains mainly the HSRV1 510 bp U3
deletion variant and trace amounts of full-length virus (Schmidt et al.,
1997). Spleen cell DNAs of six animals of each strain per virus and per
time-point were analysed by nested PCR using LTR-specific primers
(Schmidt et al., 1997) as described in the Fig. 1 legend. The numbers
indicate the number of samples, out of the six analysed, that were
positive.
CBA/Ca C57BL/6J
Infecting virus Weeks p.i … 4 12 4 12
HSRV2 5 6 1 5
HFV2 0 6 2 3
HSRV2}HFV2 (90%}10%) 4}0 5}0 4}0 6}0
HFVwt (1985) (HSRV1}HFV2) 5}0 6}0 5}0 5}0
a minor effect on the development of virus titres in acute and
persistent infection has been described for Bet−
viruses (Baunach et al., 1993 ; Yu & Linial, 1993 ; Schmidt &
Rethwilm, 1995). The different course of infection observed in
adult CBA}Ca and C57BL}6J mice was accompanied by a
different antibody response against the Bet protein. This
suggests that the Bet protein may have a role in efficient virus
spread in the infected host and}or that an immune reaction
against Bet may counteract virus spread. However, other
immunological parameters, such as the development of
neutralizing antibodies, which were not analysed in the current
study, may also contribute to the differences in the course of
infection between the two mouse strains. The availability of
the mouse model described here, of mutated infectious
molecular clones (Baunach et al., 1993) and of HFV genes
expressed by recombinant vaccinia viruses (Fischer et al., 1997)
should allow dissection of the infectious process of HFV in the
mouse in detail.
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